BHI supports an on-going project that is being held at the European Institute of Oncology by Professor Veronesi. It is the groundbreaking trial entitled ELIOT which compares intraoperative radiotherapy with conventional 6-weeks postoperative radiotherapy. The public health impact of this trial, should it be shown that these two additive treatments are equivalent, will be dramatic and obvious in terms of quality of life to patients, and massive cost savings for radiotherapy departments on a global scale.